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Abstract
Background: Upon antigen encounter, naïve B lymphocytes differentiate into antibody-secreting plasma cells. This
humoral immune response is suppressed by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) and other dioxin-like compounds, which belong to the family of aryl hydrocarbon receptor (AhR) agonists.
Results: To achieve a better understanding of the immunotoxicity of AhR agonists and their associated health
risks, we have used computer simulations to study the behavior of the gene regulatory network underlying B cell
terminal differentiation. The core of this network consists of two coupled double-negative feedback loops involving
transcriptional repressors Bcl-6, Blimp-1, and Pax5. Bifurcation analysis indicates that the feedback network can
constitute a bistable system with two mutually exclusive transcriptional profiles corresponding to naïve B cells and
plasma cells. Although individual B cells switch to the plasma cell state in an all-or-none fashion when stimulated
by the polyclonal activator lipopolysaccharide (LPS), stochastic fluctuations in gene expression make the switching
event probabilistic, leading to heterogeneous differentiation response among individual B cells. Moreover,
stochastic gene expression renders the dose-response behavior of a population of B cells substantially graded, a
result that is consistent with experimental observations. The steepness of the dose response curve for the number
of plasma cells formed vs. LPS dose, as evaluated by the apparent Hill coefficient, is found to be inversely
correlated to the noise level in Blimp-1 gene expression. Simulations illustrate how, through AhR-mediated
repression of the AP-1 protein, TCDD reduces the probability of LPS-stimulated B cell differentiation. Interestingly,
stochastic simulations predict that TCDD may destabilize the plasma cell state, possibly leading to a reversal to the
B cell phenotype.
Conclusion: Our results suggest that stochasticity in gene expression, which renders a graded response at the cell
population level, may have been exploited by the immune system to launch humoral immune response of a
magnitude appropriately tuned to the antigen dose. In addition to suppressing the initiation of the humoral
immune response, dioxin-like compounds may also disrupt the maintenance of the acquired immunity.
Background
In response to antigen stimulation, naïve B cells residing
in lymphoid organs such as the spleen and lymph nodes
differentiate terminally into antibody-secreting plasma
cells [1,2]. This adaptive humoral immune response can
be adversely affected by exposure to some environmen-
tal chemicals [3-5]. The environmental contaminant
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and other
dioxin-like compounds with similar structures suppress
humoral immunity, mainly by interfering with B cell
differentiation and subsequent antibody secretion [5-8].
These compounds, capable of producing a variety of
additional toxic responses including cancer, liver
damage, and developmental defects, pose a serious
potential risk to human health [9].
Accurate evaluation of the immune health risk from
exposure to dioxin-like compounds requires a mechanis-
tic understanding of the biochemical network that
underlies B cell differentiation and the manner in which
these chemicals interfere with the operation of the net-
work. As with many biochemical processes involved in
cell fate decisions [10-13], the differentiation of B cells
to plasma cells is mediated by a transcriptional program
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involving interacting transcription factors [1,14]. At the
core of this gene regulatory network are two coupled
double-negative feedback (mutual inhibition) loops
among three transcriptional repressors: B cell lymphoma
6 (Bcl-6), B lymphocyte induced maturation protein 1
(Blimp-1), and paired box 5 (Pax5). Specifically, Blimp-1
is able to transcriptionally repress Bcl-6 and Pax5
[15-17]; and reciprocally, both Bcl-6 and Pax5 can
repress Blimp-1 gene expression [18-20] (Figure 1). It is
likely that the coupled double-negative feedback loops
can form a bistable system, allowing cells to choose
from one of two mutually exclusive and discrete states:
naïve B cells or differentiated plasma cells [21]. Such a
bistable system would provide a basis for the all-or-none
differentiation observed with individual B cells [22-26].
Importantly, a bistable circuit would also make the dif-
ferentiation physiologically irreversible, a property that
is likely to contribute to the maintenance of the
acquired immunity after antigen encounter.
Consistent with the idea of two mutually exclusive
steady states for a bistable system, naïve B cells are
characterized by a transcriptional profile of low Blimp-1
and high Bcl-6/Pax5 expression, whereas plasma cells
feature the opposite profile: high Blimp-1 and low Bcl-
6/Pax5 [1,27]. Pax5, acting as a transcriptional repressor,
is essential for maintaining the B cell identity [28]. It
actively suppresses transcription of the immunoglobulin
molecular components including the heavy chain (IgH),
 light chain (Ig), and J chain, as well as X box pro-
tein-1 (XBP-1) which promotes the formation of the cel-
lular apparatus for immunoglobulin assembly and
secretion [29]. The transcriptional repression of these
genes by Pax5 ensures that naïve B cells neither produce
nor secrete antibodies. Upon antigen encounter, the
transcriptional profile in naïve B cells is reversed. High
expression of Blimp-1, the ‘master regulator’ of B cell
terminal differentiation, activates a number of down-
stream genes responsible for the plasma cell phenotype
[16]. Most importantly, a simultaneous decrease in Pax5
gene expression releases IgH, Ig, and J chain from
repression, leading to enhanced production and secre-
tion of immunoglobulin by plasma cells [28,29].
Depending on the type of antigen or B cell stimulus and
whether T cells are involved, distinct signal transduction
pathways may be activated to drive B cells to differenti-
ate into plasma cells [30-33]. In the case of the bacterial
endotoxin lipopolysaccharide (LPS), a polyclonal B cell
activator, the differentiation is driven, at least in part,
via AP-1, a dimeric transcription factor that upregulates
Blimp-1 gene transcription [18,34].
The suppressive effect of TCDD and dioxin-like com-
pounds on the humoral immune response is currently
believed to occur via the following mode of action. By
binding and activating the aryl hydrocarbon receptor
(AhR), TCDD inhibits AP-1 gene transcription indir-
ectly, leading to reduced AP-1 binding to the Blimp-1
promoter [35,36]. Since AP-1 mediates the action of
LPS, TCDD would thus impair the capability of LPS to
drive the switching of the transcriptional gene circuit
that underlies B-to-plasma cell differentiation, thereby
suppressing the formation of antibody-secreting plasma
cells [6]. In addition, TCDD-activated AhR binds to the
dioxin response element in the 3’ a enhancer of the IgH
gene, in a limited fashion inhibiting transcription of this
immunoglobulin component [37].
Gene expression is inherently stochastic [38]. This is
particularly true for low-abundance proteins, such as
transcription factors, for which the steady-state
Figure 1 Schematic illustration of the gene transcriptional program underlying B cell terminal differentiation and disruption by dioxin.
Consistent with the coupled mutual inhibitions among the transcriptional repressors Bcl-6, Blimp-1, and Pax5, B cells have a transcriptional profile
of high Bcl-6, low Blimp-1, high Pax5, and low IgM. Plasma cells have the inverse transcriptional profile. Arrows indicate activation, and lines
ending with a bar indicate inhibition.
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expression level may fluctuate significantly [39-44]. In
many circumstances, this intrinsic noise in protein
expression is undesirable for cellular homeostasis and as
such needs to be minimized. On the other hand there
are instances where noise in protein expression is
exploited by cells to generate advantageous non-genetic
variability in cellular phenotype [12,45-47]. When an
antigen or polyclonal B cell activator is encountered, the
all-or-none differentiation of individual B cells occurs in
a seemingly random fashion with new plasma cells
appearing at various times [22,32,34]. This heterogeneity
in the differentiation response is likely to be a key factor
contributing to the dose response pattern for a popula-
tion of B cells. It is possible that the intrinsically sto-
chastic gene expression of Blimp-1, Bcl-6, and Pax5 is
responsible for the observed heterogeneity in the differ-
entiation response among otherwise identical B cells. In
our previous work, we have suggested the emergence of
bistability with a deterministic representation of the
transcriptional network underlying B cell differentiation
[21]. In the current paper, we use a stochastic computa-
tional model of this transcriptional network (Figure 1),
constrained by experimental data, to examine how sto-
chastic fluctuations in the abundance of the key tran-
scriptional repressors can make B cell differentiation a
dose-dependent probabilistic event. The present study
indicates that the stochastic effect plays a central role in
modulating the shape, especially the steepness, of the
dose response curves for both LPS and TCDD, a result
with significant implications for quantitative risk assess-
ment of dioxin immunotoxicity.
Methods
Animals
Virus-free, female B6C3F1 mice (6 weeks of age) were
purchased from Charles River (Portage, MI). Mice were
randomized, transferred to plastic cages containing bed-
ding (five per cage), and quarantined for 1 week. Mice
were given food (Purina certified laboratory chow) and
water ad libitum and were not used until their body
weight was 17-20 g. Mice were used in accordance with
the guidelines set forth by the Michigan State University
Institutional Animal Care and Use Committee (East
Lansing, MI).
B cell isolation, activation, and TCDD addition
Spleens were isolated and made into single-cell suspen-
sions aseptically. Primary B cells were isolated from the
splenocytes by depleting all other cell types by magnetic
separation using the B cell isolation kit from Miltenyi
Biotec Inc. (Auburn, CA). B cell purity was always
greater than 95% as assessed by flow cytometry. B cells
were activated with different concentrations of LPS
(Sigma-Aldrich Co., St. Louis, MO) at 3 × 106 cells/ml
in RPMI 1640 supplemented with 10% BCS, 100 U/ml
penicillin, 100 μg/ml streptomycin, and 50 μM 2-ME.
Vehicle (0.02% DMSO) and appropriate TCDD concen-
trations (AccuStandard, New Haven, CT) were added
just prior to LPS addition in a 48-well tissue culture
plate.
ELISpot assay
ELISpot assay was performed as previously described
with a few modifications [48]. ELISpot filter plates (Mul-
tiScreen-HA) (Millipore, Billerica, MA) were precoated
with goat anti-mouse IgM antibody (Sigma-Aldrich Co.,
St. Louis, MO) at 5 μg/ml in a sodium bicarbonate buf-
fer (pH 9.6), washed and blocked with PBS containing
5% BSA. Purified B cells were washed twice and diluted
in RPMI containing 10% BCS and loaded into the cul-
ture plate wells. Typically 1-4 × 103 cells in 100 μl cell
culture media were incubated on precoated plates over-
night at 37°C with 5% CO2. After incubation, plates
were washed and biotin-conjugated goat anti-mouse
IgM antibody (Sigma-Aldrich Co., St. Louis, MO) was
added to the plates at 1 μg/ml and incubated for 2 h at
room temperature. To develop spots, streptavidin-HRP
was added (Sigma-Aldrich Co., St. Louis, MO) followed
by the aminoethylcarbazole per staining kit instructions
(Sigma-Aldrich Co., St. Louis, MO). Data was acquired
and analyzed using the CTL ImmunoSpot system (Cel-
lular Technology Ltd., Shaker Heights, OH).
Measurement of IgM Secretion
IgM secretion was measured using an enzyme-linked
immunesorbent assay protocol as previously described
[49]. Briefly, supernatants were collected from experi-
mental cultures from which LPS-induced IgM antibody
responses were evaluated. Anti-mouse IgM capture anti-
body (Sigma-Aldrich Co., St. Louis, MO) was added to
wells of a 96-well microtiter plate (100 μl/well at 5 μg/
ml) and incubated at 4°C overnight. The plate was
washed three times with 0.05% Tween-20 in PBS and
three times with dH2O. Blocking buffer (3% BSA in
PBS) was added to each well and incubated at room
temperature for at least 1.5 h. This was followed by the
same washing steps described above. Standards (mouse
IgM) or supernatant samples were then added to the
blocked plate and then incubated at 37°C for 1.5 h.
After the incubation, the plate was washed again, fol-
lowed by addition of 100 μl HRP-conjugated goat anti-
mouse IgM detection antibody. After 1.5 h at 37°C, the
plate was again washed and 100 μl ABTS (1 mg/ml;
Roche, Indianapolis, IN) was added. The detection of
the HRP substrate reaction was conducted over a 1 h
period using a Synergy HT automated Microplate reader
with a 405-nm filter (Bio-Tek, Winooski, VT). The KC4
computer analysis program (Bio-Tek, Winooski, VT)
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calculated the concentration of IgM in each well based
on a standard curve generated from the absorbance
readings of known IgM concentrations.
Model structure
The model structure is illustrated in Additional File 1:
Figure S1. Simulation of gene expression control of the
transcriptional repressors Bcl-6, Blimp-1, and Pax5 was
based on the current understanding of eukaryotic gene
regulation [43,44,50,51]. At any given time, a gene could
be in one of two discrete transcriptional states: inactive
or active, corresponding to the compact and relaxed
chromatin structure of the promoter, respectively. Once
in the active state (GENE1, Additional File 1: Figure S1),
the gene is transcribed at a relatively constant rate; in
the inactive state (GENE0), no transcription occurs.
Transitions between the inactive and active states (i.e.,
gene activation and deactivation) are controlled by tran-
scriptional activators and repressors specifically targeting
the promoter. In addition to promoter transition, subse-
quent steps including transcription, translation, and
mRNA and protein degradation were modeled for each
of the three transcriptional repressors. Since these key
steps contribute, to varying degrees, to the stochastic
fluctuation of gene expression [38-44], their explicit
inclusion adds variability to the switching behavior of
the bistable circuit. In turn, the stochastic behavior of
the bistable switch likely forms the basis for the hetero-
geneous differentiation response observed for a popula-
tion of B cells stimulated with an antigen or B cell
activator [22,32,34].
The negative mutual regulation among Bcl-6, Blimp-1,
and Pax5 is modeled based on the modes of repression
reported in the literature. Blimp-1 represses gene
expression of both Bcl-6 and Pax5 [15-17]. As a tran-
scriptional repressor, Blimp-1 suppresses target genes by
recruiting co-repressors such as histone deacetylase, his-
tone methyltranferase, and those belonging to the Grou-
cho family [52-54]. Functioning as chromatin-modifying
enzymes, these co-repressors alter the local chromatin
structure to a compact (transcriptionally inactive) state.
Based on this active mode of repression, the transcrip-
tional repression of Bcl-6 and Pax5 by Blimp-1 was
implemented by having Blimp-1 promote the deactiva-
tion step of these two genes. Pax5 in turn represses
Blimp-1 gene expression directly [20], also by an active
mechanism mediated through recruitment of co-repres-
sors from the Groucho family [55,56]. Therefore, repres-
sion of Blimp-1 by Pax5 was implemented by having
Pax5 promote the deactivation step of Blimp-1 gene.
Although the transcriptional repressor Bcl-6 may
directly bind to target genes, it exerts its effect on
Blimp-1 indirectly through AP-1. By binding and
sequestering AP-1, Bcl-6 blocks its transcriptional
activity, thus functioning as a passive repressor [18].
Since AP-1 positively regulates Blimp-1 gene expression,
repression of Blimp-1 by Bcl-6 was implemented by hav-
ing Bcl-6 impinge upon the activation step of Blimp-1
gene, thus curbing the maximal induction of Blimp-1 by
AP-1. Through these specific transcriptional regulations,
a gene circuit is established in the form of coupled dou-
ble-negative feedback loops among Bcl-6, Blimp-1, and
Pax5 (Additional File 1: Figure S1).
Activation of the transcriptional program underlying B
cell terminal differentiation occurs in a stimulus-depen-
dent manner, involving various cytokines and cell sur-
face receptors [14]. In the case of LPS, binding to its
cognate Toll-like receptor 4 (TLR4) initiates a sequence
of intermediate intracellular signaling events, culminat-
ing in the activation of the AP-1 protein complex
[34,35]. For simplicity, the activation of AP-1 by LPS-
bound TLR4 was modeled as a single phosphorylation
event. Like many other membrane-residing receptors,
TLR4 is usually downregulated after occupied by LPS,
possibly through a desensitization mechanism that
includes receptor internalization [57,58]. Downregula-
tion of TLR4 was implemented here by ascribing a
higher rate constant to the turnover of the LPS-bound
receptor compared to that of the free receptor. Inclusion
of TLR4 downregulation enables the model to recapitu-
late the attenuation of AP-1 signaling in time following
its initial activation, as observed in B cells stimulated
with LPS and other cytokines [34,35].
The suppression of AP-1 activity by TCDD in LPS-
activated B cells was assumed to occur in an AhR-
dependent manner. Although the precise mechanism for
this process is unknown, a decrease in the AP-1 subunit
c-jun was observed in the AP-1 DNA-binding complex
in the presence of TCDD [35]. For simplicity, AP-1 was
treated as a single entity in our model with its synthesis
rate negatively regulated by TCDD. In the absence of
detailed information at the molecular level on the sig-
naling pathways by which TCDD-AhR affects AP-1, the
specific regulation of AP-1 by TCDD-AhR was
described in the equation as a continuous function of
the concentration of TCDD-AhR. Immunoglobulin M
(IgM), which consists of several subunits, was also mod-
eled as a single entity subject to negative control by
both Pax5 and AhR. A first-order secretion rate was
assumed for intracellular IgM, with the rate constant
large enough that intracellular degradation of IgM is
negligible.
Model implementation and modeling tools
Reaction details including ordinary differential equa-
tions, parameter values, and initial steady-state condi-
tions are provided in Additional File 1: Tables S1 - S3.
Unless otherwise indicated, the unit of abundance used
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for state variables in the model is number of molecules
per cell. The deterministic version of the model was
implemented in PathwayLab (InNetics Inc., Linköping,
Sweden), while the stochastic version was implemented
in the BioNetS program [59], based on Gillespie’s sto-
chastic simulation algorithm [60]. Both versions of the
model were exported into MatLab (The Mathworks,
Inc., Natick, MA, USA) for analysis and simulation. The
model in SBML format is provided in Additional File 2.
Bifurcation diagrams were generated using the XPP-
AUT program [61]. The effective Hill coefficients (nH)
of simulation-generated dose response curves were esti-
mated by using the equation nH = ln81/ln(X90/X10),
where X90 and X10 are the doses that produce 90% and
10% of the maximal response, respectively.
Results
Bistability of the coupled double-negative feedback loops
The coupled feedback loops comprising Bcl-6, Blimp-1,
and Pax5 exhibit bistability, a desirable systems property
for cells undergoing differentiation [62]. The undifferen-
tiated and differentiated cellular states are unambigu-
ously separated, relatively stable, and the transition from
the former to latter state is physiologically irreversible
(Figure 2). The bistable property of a feedback system
can be graphically analyzed by the reciprocal open-loop
steady-state stimulus-response relationships between any
pair of variables in the feedback loops [63]. Here we
describe such stimulus-response relationships in the
multivariable model as “null curves” for their correspon-
dence to nullclines in a two-variable system. Null curves
were obtained for the Blimp-1 and Pax5 variable pair
(Figure 2A) at the unperturbed condition (LPS = 0 and
TCDD = 0). The two null curves intersect three times,
indicating three possible steady states at which the sys-
tem can settle. Intersection points 1 and 3 are stable
steady states, representing the resting mature B cell (low
Blimp-1 and high Pax5) and plasma cell (high Blimp-1
and low Pax5) states, respectively. Intersection point 2,
situated between the two stable states, represents an
unstable steady state. These three steady states are
essentially projections onto the Blimp-1-Pax5 plane of
the attainable fixed points of the system in multi-dimen-
sional phase space. In that phase space, an imaginary
boundary passing through point 2 (corresponding to the
“separatrix” for a two-variable system) divides the phase
space into two basins of attraction [64]. On one side of
the boundary, the system tends to converge to the B cell
Figure 2 Analysis of bistability in the gene regulatory network underlying B cell terminal differentiation (see Additional File 1:
Supplementary Material for model details). (A) Steady-state stimulus-response curves between Blimp-1 and Pax5 under zero LPS and TCDD.
The red curve was obtained with Blimp-1 level as the independent variable (i.e., stimulus) and the steady-state level of Pax5 as the response; the
blue curve was obtained with Pax5 level as the independent variable and the steady-state level of Blimp-1 as the response. The blue curve
represents an ultrasensitive response of Blimp-1 to Pax5 due to the presence of the Bcl-6/Blimp-1 double-negative feedback loop. The
ultrasensitivity enables the blue curve to intersect with the red curve at three points, indicative of bistability. Intersection point 1 represents the
stable B cell state; intersection point 3 represents the stable plasma cell state; and intersection point 2 is an unstable steady state. (B) Bifurcation
analysis using AP-1p (active form of AP-1) as the independent parameter. Vertical arrows indicate that there is a deterministic threshold value of
AP-1p required to turn on the bistable switch. Leftward arrows indicate that the bistable switch is irreversible even when AP-1p drops back to
the basal level of 100.
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state; on the other side, it converges to the plasma cell
state.
By activating AP-1, LPS triggers the differentiation of
B cells to plasma cells. Bifurcation analysis (Figure 2B)
indicates that as the steady-state AP-1p (active form of
AP-1) level increases (rightward arrows), Blimp-1
increases and Pax5 decreases initially by small amounts.
However, once AP-1p reaches a threshold value of
about 200 molecules, the B cell switches in a discrete
fashion to a plasma cell state (vertical arrows). This
abrupt transition underlies an all-or-none, switch-like
response and signifies a true discontinuity that precludes
the cell from settling at an intermediate state. The
switch also exhibits hysteresis. Starting from the plasma
cell state, as AP-1p is reduced (leftward arrows) to its
basal level (~100), the system remains in the differen-
tiated plasma cell state with high Blimp-1 and low Pax5/
Bcl-6 levels. In the context of humoral immune
response, this irreversibility of the switch ensures that
the antibody-secreting plasma cell phenotype persists
after the initial antigen stimulus recedes, thus serving as
a maintenance mechanism for the acquired immunity.
Stochastic response of B cells to LPS stimulation
In a deterministic model of a bistable system, the occur-
rence of switching from one state to the other and the
time when it occurs are uniquely determined by the
level of the input stimulus [21]. If the biochemical cir-
cuits are nearly identical across a population of B cells,
the individual responses of these cells would be
expected to be similar. However, experimental observa-
tions indicate that the responses of individual cells to a
given activator are rather heterogeneous [22,32,34], even
in an isogenic B cell population [65]. Some cells differ-
entiate into antibody-secreting plasma cells at early
times, some do so at late times, and many cells remain
undifferentiated in the time window of observation.
Thus the number of plasma cells that appear after B cell
activation is time-dependent. This heterogeneous
response pattern is likely to be important in shaping
dose response behaviors, which are quantitative mea-
surements necessary for evaluating the health risk of
immune-suppressive chemicals. Therefore a more expli-
cit description of the heterogeneous response of indivi-
dual B cells is needed than is provided by a
deterministic model.
Heterogeneity in the occurrence and timing of indivi-
dual B cell differentiation is likely to result from sto-
chastic fluctuations in gene expression of the key
transcription factor Bcl-6, Pax5, and in particular,
Blimp-1 - as discussed below. We have simulated this
scenario using the BioNetS program [59] based on Gil-
lespie’s stochastic algorithm [60]. Since Blimp-1 is
expressed at a low level in the B cell [66], it exhibits a
pulsatile expression pattern and is much more “noisy”
than Bcl-6 or Pax5 (Figure 3, left panels). The coefficient
of variation, a measure of the noise level, of Blimp-1 is
almost seven times greater than that of Bcl-6 and Pax5
(Figure 3, right panels). Most of the noise in Bcl-6 and
Pax5 protein expression actually originates from Blimp-
1. This can be demonstrated by replacing the stochastic
input from Blimp-1 to Bcl-6 and Pax5 genes with a con-
stant equal to the mean Blimp-1 level in the B cell state,
whereby the noise in expression of Bcl-6 and Pax5 is
significantly reduced (Additional File 1: Figure S2).
Despite the noisy expression of Blimp-1, Bcl-6 and
Pax5, the B cell state is very stable: in the absence of
LPS, only a negligible fraction of B cells (about 0.02%)
switch spontaneously to the plasma cell state in 200
hours. However, the stochastic fluctuations in gene
expression, particularly of Blimp-1, are sufficiently high
that the switching behavior of the bistable gene circuit
in response to LPS stimulation becomes probabilistic
and exhibits substantial cell-to-cell variability. For exam-
ple, among five stochastically simulated B cells tracked
over a period of 72 h under 10 μg/ml LPS (Figure 4,
solid lines), two became activated at different time
points, as reflected in the decrease in Bcl-6 (data not
shown) and Pax5 levels, and increase in Blimp-1 and
IgM protein levels. The other three cells remained unre-
sponsive, thus reproducing the expected all-or-none dif-
ferentiation response of individual B cells. In contrast to
the divergent switching behavior of the core bistable
gene circuit itself, activation of the upstream AP-1 pro-
tein by LPS follows a similar pattern in deterministic
and stochastic simulations - trajectories for the five sto-
chastically simulated B cells closely clustered around the
deterministic result (Figure 4, top left panel). The desen-
sitization of TLR4 through internalization (as discussed
in the Methods section) causes the rise in AP-1p level
to be transient. Interestingly, the deterministic imple-
mentation of the circuit does not turn on the bistable
switch at all (Figure 4, dashed lines: Blimp-1 and IgM
levels remain low), even with saturating LPS concentra-
tions. This outcome indicates that while AP-1p may
transiently exceed the threshold value (~200, see Figure
2B), it does not persist above that level long enough to
activate the bistable switch deterministically. Nonethe-
less, the same parameters are sufficient to cause a signif-
icant number of B cells to switch into plasma cells in a
noisy gene expression environment.
The effect of probabilistic switching in a population of
B cells under LPS stimulation is better visualized by
simultaneous monitoring of Blimp-1 and Pax5 gene
expression in our stochastic simulations, analogous to
experiments using dual-fluorescence flow cytometry
(Figure 5). These simulations produced largely two dis-
tinct clusters of data points, representing naïve B cell
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(low Blimp-1 and high Pax5) and plasma cell (high
Blimp-1 and low Pax5) populations, respectively. The
data points located in between these two clusters (parti-
cularly at 24 and 48 h) represent the small number of
cells still in the process of switching from the B cell to
the plasma cell state. The plasma cell cluster gradually
grows in size over a period of 72 h, representing hetero-
geneous responses among a population of individual B
cells. A higher LPS dose results in higher plasma cell
formation at each time point (Figure 5, lower panels).
The dynamics of these time- and dose-dependent
changes in the percentage of plasma cell formation is
qualitatively similar to the experimental results observed
with primary mouse B cells (Figure 6A, top and middle
panels). In the first 24 h, the response is relatively small,
due likely to the time required for completion of the
switching process. The largest increase in the plasma
cell population occurs between 24-48 h, before slowing
dramatically between 48-72 h, a result related to the
decline in AP-1p levels (Figure 4). The simulated dose
response for percentage plasma cell formation at 72 h
adequately recapitulates the experimental observations
(Figure 6A, bottom panel). The curve, with an estimated
apparent Hill coefficient of 1.20, does not appear to
have abrupt changes, suggesting that the number of
plasma cells formed is largely a graded function of the
LPS dose. Experimental measurement and computer
simulation both show that accumulated IgM secretion
accelerates over the entire period of observation (Figure
6B, top and middle panels). As with percentage of
plasma cell formation, the predicted response for IgM
secretion at 72 h also appears to be a graded function of
LPS dose (Figure 6B, bottom panel). The estimated Hill
coefficient is 1.19, similar to that for plasma cell
Figure 3 Simulated stochastic gene expression of Bcl-6, Blimp-1, and Pax5 in the B cell state. The histograms (right panels) generated
from a population of 105 simulated cells illustrate the degree of variability in protein abundance (noise). The noise level is quantified by the
coefficient of variation, s/μ (where s is the standard deviation and μ the mean). Due to the low abundance in B cells, Blimp-1 expression is
much more noisy (larger s/μ) than Bcl-6 and Pax5, and fluctuates in a pulsatile manner. The stochastic, pulsatile expression of Blimp-1 is
primarily responsible for the heterogeneous switching response of individual B cells to LPS stimulation.
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formation. A more detailed examination of the low-dose
effect of LPS further confirms that regardless of the
endpoint response examined, the B cell population as a
whole would respond in a continuous, graded fashion to
increasing doses of LPS (Additional File 1: Figure S3),
even as the switching of individual cells is all-or-none.
To examine how the level of noise in gene expression
affects the shape and steepness of the dose response
curves, we tuned the noise level of Blimp-1 in the
model. This was done by simultaneously altering the
transcription and translation rate constants of Blimp-1
by similar magnitudes, but in opposite directions, such
that the deterministic steady-state level of Blimp-1 pro-
tein remained the same [39]. In addition to suppressing
the maximal response for percentage of plasma cell for-
mation and IgM secretion (Figure 7, top panels),
increasing noise level in Blimp-1 gene expression tends
to decrease the steepness, as illustrated by the normal-
ized responses (Figure 7, bottom panels), and conse-
quently the Hill coefficient (Table 1) of the dose
response curves for LPS. Decreasing the noise level has
the opposite effect. In addition, a higher degree of sto-
chastic fluctuation in Blimp-1 protein level also shifts
the dose response curves to the left with a decreasing
ED50 value (Figure 7, bottom panels; also see Table 1).
Disruption of the bistable switch by TCDD
Acting via AhR, TCDD and dioxin-like compounds dis-
rupt B cell terminal differentiation and immunoglobulin
production by repressing gene transcription of the AP-1
protein and components of IgM [35-37]. Simulations of
the B cell transcription network show that TCDD inhi-
bits, in a dose-dependent manner, both the number of
plasma cells formed and aggregated IgM secretion in
response to LPS stimulation (Figure 8, top panels). The
maximal suppression is about 30% of the control level,
comparable to that observed experimentally with pri-
mary B cells (Additional File 1: Figure S4) and consis-
tent with earlier reports [6,67,68]. As with LPS
activation, the TCDD dose response curves also appear
to be graded, with Hill coefficients of 1.12 and 0.98 for
percentage of plasma cell formation and IgM secretion,
respectively (Figure 8, bottom panels; and Additional
File 1: Figure S5 for low concentrations of TCDD). In
the network described here, the suppressive effect of
TCDD on the probability of B cell differentiation arises
from attenuation by TCDD of the LPS-induced transient
activation of AP-1 (Additional File 1: Figure S6). As pre-
viously discussed, this step serves as the trigger switch-
ing the bistable gene circuit from the B cell to the
plasma cell state. To further characterize the suppressive
Figure 4 Heterogeneous responses of stochastically simulated B cells under continuous stimulation with 10 μg/ml LPS for 72 h. Of the
five simulated B cells, two cells clearly turn on the bistable switch, becoming IgM-secreting plasma cells; the other three remain unresponsive.
Dashed gray lines are trajectories from deterministic simulations, indicating that the bistable circuit is not switched on with the same set of
parameter values in a deterministic model.
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effects of TCDD, various combinations of LPS and
TCDD concentrations were applied to the stochastic
model. The simulated response surfaces at 48 and 72 h
appear to exhibit gradual changes with respect to both
LPS and TCDD concentrations (Figure 9), devoid of the
precipitous transitions expected for a bistable system
described with a set of deterministic equations.
Despite the fact that most plasma cells do not appear
until about 24 h after the onset of LPS stimulation (Fig-
ure 6A), previous in vitro studies have demonstrated
that effective suppression of plasma cell formation by
TCDD requires that TCDD be present in the first 24 h
following antigen challenge [6,69]. Simulations of the
modeled network produce similar behaviors. As the
onset of TCDD treatment is progressively delayed rela-
tive to LPS stimulation, the TCDD-induced suppression
of plasma cell formation is gradually diminished, and
completely lost for delays greater than 36 h (Figure 10).
Although the molecular basis for this time-dependent
suppression is not fully understood, the transience of
antigen-stimulated AP-1 activation in our B-cell differ-
entiation network is the key component responsible for
the limited window of susceptibility to TCDD suppres-
sion. The desensitization of TLR4 after LPS binding in
our model causes the AP-1p level to rise transiently,
which then declines by 24 h and nearly returns to the
baseline by 36 h (Figure 4). Were TCDD treatment
started between 24 and 36 h, the time period of most
effective suppression of LPS-induced AP-1 activation (i.
e., 0-24 h) would be missed. B cells that have already
committed to turning on the bistable switch within the
first 24 h are irreversibly on the way to the plasma cell
state and would not be affected by TCDD added at a
later time.
As with many cell differentiation events, the differen-
tiation of B cells to antibody-secreting plasma cells is
believed to be a physiologically irreversible process. Our
analysis suggests that the hysteresis inherent in the bis-
table switch comprising Bcl-6, Blimp-1, and Pax5 (Fig-
ure 2B) is responsible for this irreversibility. A
bifurcation analysis in the absence of LPS reveals that as
the concentration of TCDD is increased (Figure 11A),
the plasma cell state (represented by the upper branch
of the Blimp-1 vs. TCDD bifurcation diagram and lower
branch of the Pax5 vs. TCDD bifurcation diagram)
moves closer to the intermediate unstable steady state
(dashed branches), although the two states never coa-
lesce for high TCDD concentrations. This behavior
Figure 5 Stochastic simulations indicating all-or-none, but heterogeneous responses in individual B cells using Blimp-1 and Pax5 as
dual expression markers. The B cell population (1000 cells) splits into two distinct clusters under continuous LPS stimulation for 72 h - the
cluster with low Blimp-1/high Pax5 represents B cells, while the cluster with high Blimp-1/low Pax5 represents plasma cells. Individual B cells
switch to the plasma cell state randomly over time and higher LPS concentration results in more plasma cells. Top panels: 1 μg/ml LPS, bottom
panels: 10 μg/ml LPS. Note: to help visualize cells with zero copy number of Blimp-1 or Pax5 proteins on logarithmic scale, a number drawn
randomly from a log-normal distribution (with mean = 1 and variance = 0.1) was added to the simulated protein expression data. This in effect
mimics background fluorescence in flow cytometry studies measuring protein expression.
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suggests that the stable plasma cell state approaches the
boundary in phase space that separates the basin of
attraction of the B cell state from that of the plasma cell
state. There is thus an increased probability that in the
presence of TCDD, the stochastic fluctuations in the
levels of key transcriptional repressors, especially those
expressed at low levels in the plasma cell (i.e., Pax5 and
Bcl-6), may swing the system across the fate-dividing
boundary to the B cell state. This suggests that TCDD
could disrupt the stability of the plasma cell state, mak-
ing the B-to-plasma cell differentiation process reversi-
ble. In agreement with this prediction, stochastic
Figure 6 Comparison of experimental and stochastic simulation results for percentage of plasma cell formation (A) and accumulated
IgM secretion (B) under continuous LPS stimulation for 72 h. The simulated LPS dose response curves obtained at 72 h for percentage
plasma cells (A, bottom panel) and IgM secretion (B, bottom panel) have an estimated Hill coefficient of 1.20 and 1.19, respectively. A simulated
cell is counted as a plasma cell if the IgM level in the cell is above 200. The same standard was used for results shown in other figures.
Accumulated IgM secretion data were normalized to the maximum value at 72 h for comparison. In vitro experimental results were from
triplicate samples of primary mouse B cells for each LPS concentration, while simulation results were obtained from 104 stochastically simulated
cells for each LPS concentration.
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simulations indicate that for a population of plasma cells
subject to continuous presence of TCDD, the number of
plasma cells decreases over time in a seemingly expo-
nential fashion with the rate of reversion increasing with
TCDD concentrations (Figure 11B).
Discussion and Conclusions
Many cellular processes in living organisms, including
sex determination, lineage specification, cell differentia-
tion, proliferation, and apoptosis, are irreversible, all-or-
none (binary) phenomena. It is increasingly recognized
that such binary cellular processes are controlled by bis-
table biochemical circuits, which ensure the discreteness
and irreversibility of these processes [62,70]. Most cellu-
lar bistable systems are based on molecular circuits of
mutual activation and/or mutual inhibition between
Figure 7 Simulated effects of stochastic noise in Blimp-1 gene expression on the LPS dose response curves for (A) percentage of
plasma cell formation and (B) averaged accumulated IgM secretion per cell. The dose response curves were obtained from 104 simulated
cells under continuous LPS stimulation for 72 h. Blimp-1 noise level was decreased (increased) by simultaneously increasing (decreasing) Blimp-1
transcription rate constant (k13) and decreasing (increasing) Blimp-1 translation rate constant (k15) by the same 5-fold from default values, an
alteration that kept the deterministic steady-state level of Blimp-1 protein unchanged. The estimated Hill coefficient and ED50 values are shown
in Table 1.
Table 1 Effects of noise in Blimp-1 protein expression on
the steepness and position of the LPS dose response
curves.
% plasma Cells IgM Secretion
Blimp-1 noise nH ED50 nH ED50
1.423 1.253 1.074 1.260 1.100
1.928 1.201 0.755 1.188 0.843
3.482 0.959 0.570 1.023 0.650
Note: The quantitative effects of altering Blimp-1 noise level were evaluated
for the dose response curves of percentage of plasma cell formation and IgM
secretion presented in Figure 7. Blimp-1 noise level is expressed as the
coefficient of variation of Blimp-1 protein abundance. The default parameter
values of the model generate a coefficient of variation of 1.928. The lower
(higher) noise level of 1.423 (3.482) was obtained by increasing (decreasing)
Blimp-1 transcription rate constant (k13) and decreasing (increasing) Blimp-1
translation rate constant (k15) by 5-fold, which kept the deterministic steady-
state level of Blimp-1 protein unchanged. nH, Hill coefficient; ED50,
concentration of LPS (μg/ml) producing 50% of the maximum response.
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genes and proteins [71]. These molecular circuits often
involve a number of proteins forming multiple feedback
loops, as observed in systems for cell cycle control,
oocyte maturation in Xenopus laevis, cell lineage specifi-
cation and differentiation, etc [11,72-75]. The coupling
of multiple feedback loops is believed to provide redun-
dancy as well as robustness to the bistable property of
the entire circuit [73,76]. In the B cell transcriptional
network, double negative feedback loops between Bcl-6,
Blimp-1, and Pax5 are coupled at the Blimp-1 node.
The resulting bistability produces two mutually exclusive
transcriptional profiles: (1) high Bcl-6/Pax5 and low
Blimp-1, representing the B cell state; and (2) low Bcl-6/
Pax5 and high Blimp-1, representing the plasma cell
state (Figure 2A). This mutual exclusivity of stable gene
expression patterns ensures definitive separation
between two discrete cellular phenotypes and an all-or-
none response in individual B cells to antigen stimula-
tion. Further, once a B cell differentiates into a plasma
cell, the plasma cell phenotype is retained even if the
stimulating antigen is removed. This irreversibility is
underpinned by hysteresis, another important biological
property conferred by the bistable system (Figure 2B).
The switching from the B cell to plasma cell state is
stimulated by specific antigens or polyclonal activators.
In the case of LPS, the switching is mediated by altera-
tions in concentration of active AP-1 protein (AP-1p)
and characterized by a threshold concentration of AP-
1p (Figure 2B). This in turn suggests a threshold for
LPS, the initiating stimulus, and a switch-like dose
response in a deterministic setting. In reality, the bis-
table gene circuit in the B cell has to operate in an
inherently stochastic environment within the nucleus,
which is likely to produce significant cell-to-cell variabil-
ity. Our experimental data shows that individual B cells
differentiate into plasma cells in a rather heterogeneous
manner, with the percentage of plasma cells formed
appearing to be a graded function of the LPS dose,
devoid of the sharp transitions expected for an all-or-
none bistable switch (Figure 6A). By considering the sto-
chasticity in gene expression, our simulations recapitu-
late these observations. Thus whether a particular B cell
will respond or not within a given time window of LPS
stimulation, as well as the timing of the response, are
both chance events resulting from intrinsically stochastic
gene expression.
Due to the low expression level of Blimp-1 in B cells
[66], its abundance is likely to show considerable
moment-to-moment and cell-to-cell variability. In our
implementation of the B-cell differentiation network,
Blimp-1 fluctuates in a nearly pulsatile manner (Figure
3), which is consistent with the phenomenon of pulsatile
mRNA production and bursting of protein translation
observed for genes with low expression [77-80]. In the
Figure 8 Simulated suppressive effect of TCDD on LPS-stimulated (A) percentage of plasma cell formation and (B) averaged
accumulated IgM secretion per cell. The results were obtained from 104 simulated cells under continuous LPS (15 μg/ml) and TCDD
treatment for 72 h. The dose response curves with respect to TCDD obtained at 72 h for percentage plasma cells (A, bottom panel) and IgM
secretion (B, bottom panel) have an estimated Hill coefficient of 1.12 and 0.98, respectively.
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phase space of the bistable system, mature B cells would
reside on one side of an imaginary boundary separating
the two basins of attraction for the B cell and plasma
cell states. Even in the absence of LPS, an occasional
pulse in Blimp-1 expression may be large enough to
send the system across the boundary to the plasma cell
state. This might explain the spontaneous appearance of
a negligibly small fraction of plasma cells observed in a
population of B cells in vitro in the absence of any anti-
gen [22,23,34,81]. Exposure to LPS, which activates the
AP-1 protein, leads to increased Blimp-1 gene transcrip-
tion. Due to the stochastic nature of Blimp-1 gene
expression, the LPS-induced increase in Blimp-1 abun-
dance takes the form of more frequent and larger
Blimp-1 pulses (Additional File 1: Figure S7). These
pulses increase the probability of the system crossing
the fate-separating boundary and then being attracted to
the plasma cell state eventually. Our analysis suggests
Figure 9 Simulated dose response surfaces for percentage of plasma cell formation at 0, 24, 48, and 72 h time points under
continuous treatment with various combinations of LPS and TCDD concentrations. The results were from 104 simulated cells for each
concentration combination.
Figure 10 Simulated effect of the timing of TCDD treatment on
LPS-stimulated B cell differentiation. The results were from 104
simulated cells with LPS at 10 μg/ml and TCDD at 10 nM. LPS
treatment was continuous from 0 to 72 h. TCDD treatment started
at different times as indicated and continued till 72 h.
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that the cell-to-cell variability in Blimp-1 pulses at a
given moment explains the heterogeneous switching
behavior of individual B cells. Previous computational
studies have shown that stochastic fluctuations could
obscure the threshold of the switching behavior of a bis-
table system, making the dose response less switch-like
[82,83]. In our implementation of the B cell differentia-
tion network, sufficiently large stochastic fluctuations in
Blimp-1 expression result in substantially graded
response for percentage plasma cell formation with an
estimated Hill coefficient close to 1. This number, a
measure of the steepness of the dose response curve, is
inversely correlated with the level of noise in Blimp-1
protein expression (Figure 7 and Table 1).
In summary, the bistable gene circuit operating in a sto-
chastic environment in B cells confers two essential prop-
erties to the humoral immune response. First, bistability
ensures that distinct, mutually exclusive phenotypes are
associated with the B cell and plasma cell, and that the
switching from the B cell to plasma cell phenotype is irre-
versible so as to maintain the acquired immunity for a per-
iod of time following antigen encounter. Second,
stochastic fluctuations in protein expression provide the
necessary variability for the differentiation response to
becomes probabilistic. This allows the number of plasma
cells formed and the total amount of antibody produced
to scale in a graded manner with the antigen dose.
Numerous studies have shown that noise in protein
expression can be exploited by cells to generate necessary
non-genetic variability in cellular phenotype and fate
[12,45-47,84-86]. For example, intrinsic noise in ComK
protein expression in the soil bacterium Bacillus subtilis
allows a small fraction of cells to reside in the competent
state capable of DNA uptake rather than in a vegetative
state. This strategy increases fitness of the species by
increasing phenotypic diversity among a population of
genetically identical bacteria [12,87]. A recent study by
Spencer et al. demonstrated that protein expression noise
may be responsible for the variability in apoptotic response
observed in clonal populations of mammalian cells [45]. It
is thus likely that noise in gene expression is utilized by B
cells to launch a humoral immune response of appropriate
magnitude (as measured by the extent of plasma cell for-
mation and aggregated IgM secretion) in handling the
amount of pathogen in the body. This proposed effect of
variability at the molecular level on the overall dose
response curves is similar to the hypothesis on chemical
carcinogenesis at the human population level proposed by
Lutz, which states that even if each human individual had
a specific response threshold for a carcinogen, variability
among individuals would result in a continuous dose
response curve for a human population [88].
Figure 11 Simulated effect of TCDD in destabilizing the plasma cell state. (A) Bifurcation analysis in the absence of LPS indicates that as
the concentration of TCDD increases, the plasma cell state (upper branch of the Blimp-1 vs. TCDD bifurcation diagram and lower branch of the
Pax5 vs. TCDD bifurcation diagram) move closer to the intermediate unstable steady state (dashed branches), although they never coalesce. (B)
Stochastic simulation using 104 plasma cells demonstrated that TCDD destabilized the plasma cell state over time in a dose-dependent manner.
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The molecular basis of the immunosuppressive effect
of the environmental contaminant TCDD and similar
compounds acting through AhR remains incompletely
understood at the molecular level. A primary goal in
developing cell-based quantitative network simulations
of toxic response is to evaluate the shape of the dose
response curve over a broad range of exposures. To this
end, it is necessary to acquire mechanistic understand-
ing of how dioxin-like compounds interact with the
gene transcriptional network underlying the B cell term-
inal differentiation program. As we have tried to demon-
strate in the current work, computational modeling
approaches can be helpful in attaining this goal.
Through activation of the AhR signaling pathway,
TCDD, a potent dioxin compound, suppresses AP-1 sig-
naling, a key mediator of B cell differentiation [35,36].
This attenuation of antigen-stimulated AP-1 activation
by TCDD (Additional File 1: Figure S6) makes it more
difficult for a B cell to switch to the plasma cell state. In
a stochastic gene expression context, this inhibitory
effect of TCDD is manifested as a reduction in the
probability of B cell differentiation. With fewer anti-
body-secreting plasma cells formed, the humoral immu-
nity is compromised. Importantly, stochasticity in gene
expression of transcription factors transforms the binary,
all-or-none response occurring in individual B cells into
a much more graded response to TCDD for a popula-
tion of B cells (Figure 8). Our computational model,
which incorporates as default a continuous description
of TCDD affecting AP-1 and simulates in vitro experi-
mental scenarios, suggests that the graded nature of the
suppressive effect on B cell differentiation may extend
well into the low-dose region, where no abrupt transi-
tions were observed (Additional File 1: Figure S5).
Differentiation of mature B cells into plasma cells is a
terminal, physiologically irreversible process. Some of
the newly differentiated plasma cells migrate to the
bone marrow, where, aided by survival signals from
stromal cells, they can survive for several months
[89-91]. Independent of memory B cells, these long-
lived plasma cells contribute to acquired immunity
against pathogens by continuing to secrete antibody
molecules for an extended period of time. While the
effect on B cell differentiation has been a focus of
research concerning immunotoxicity of TCDD and
related compounds, its possible effect on the fate of
terminally differentiated plasma cells has not received
much attention. In its present form, our B cell response
network suggests that TCDD may alter the phase space
landscape of the transcription program, bringing the
plasma cell state closer to the boundary separating it
from the B cell state (Figure 11A). This would make it
easier for stochastic fluctuations to switch plasma cells
back to the B cell state. This behavior occurs in the
stochastic implementation but not in the deterministic
mode with an identical parameter set. Stochastic simula-
tions suggest that TCDD destabilizes plasma cells in a
dose-dependent manner, possibly allowing these cells to
dedifferentiate back to a B cell phenotype (Figure 11B).
While the predicted decline in the number of plasma
cells due to phenotype reversal is a slow process, the
impairment to the acquired humoral immunity could be
tangible, given that long-lived plasma cells may survive
in the bone marrow for up to several months [89-91].
Although cell differentiation is traditionally regarded
as a physiologically irreversible process, gene manipula-
tion in terminally differentiated cells has been shown to
successfully reprogram these cells to progenitor or even
stem cell states [92-95]. Among immune cells, the B cell
lineage itself has considerable plasticity [96,97]. B cells
can be dedifferentiated by genetic manipulation to pre-
cursor cells, and thereafter diverted through intermedi-
ate states to fully differentiated T cells or macrophages
[98,99]. Transiently expressing ectopic Bcl-6 and asso-
ciated co-repressor MTA3 in plasma cell lines reversed
the phenotype to that of B cells [100]. This finding is
consistent with our model of the underlying bistable
gene circuit, where TCDD first represses AP-1 and
Blimp-1, leading to upregulation of Bcl-6 and Pax5, and
consequent destabilization of the plasma cell state.
While this prediction requires further study, it could
have important implications for the immunotoxicity of
TCDD. If confirmed, it would imply that besides sup-
pressing initiation of the humoral immune response by
inhibiting plasma cell formation, TCDD and similar
compounds may disrupt the maintenance of the
humoral response through destabilization of long-lived
plasma cells.
Although the stochastic model presented here repro-
duces some experimental observations, the entire tran-
scriptional network of B cell differentiation is potentially
far more complex. Besides Bcl-6, Blimp-1, and Pax5,
additional transcription factors such as Bach2, IRF-4,
Mad1, and MTA3 are also involved in regulation of B-
to-plasma cell differentiation [26,33,101-103]. Additional
feedback loops may also exist, for example between
Blimp-1 and IRF-4 [103]. The molecular pathways med-
iating the toxicity of TCDD are also likely to be more
extensive than the impairment of AP-1 signaling. For
instance, the role of the AhR repressor protein in
TCDD signaling may need to be considered [104]. An
important purpose of risk assessment for TCDD and
other dioxin-like compounds is to establish specific
“safe” values of exposure in the low-dose region, below
which adverse biological effects are negligibly small.
However, low-dose effects are generally more difficult to
measure precisely and economically, as the variability
associated with measured endpoints is usually large,
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obscuring the change in curvature of the low-dose
region. Estimation of low-dose effects is therefore fre-
quently made by extrapolation from high-dose data or
computer simulations. In the present study, we show
that a mechanistic, systems-level computational model
of the B cell transcriptional network incorporating sto-
chastic gene expression could generate dose response
curves for a broad range of doses in agreement with
experimental measurements. However, its value in accu-
rately predicting low-dose effects for both LPS and
TCDD is currently limited. A more confident prediction
would likely require greater structural and kinetic details
of pertinent signaling pathways leading from exposure
to LPS and TCDD up to the bistable circuit, and per-
haps a more complete description of the bistable circuit
itself. Finally, for in vivo toxicity prediction, the cellular
model has to be linked to dosimetry models that calcu-
late the concentrations of dioxin-like compounds in
immune tissues for environmental exposures.
In conclusion, we demonstrate that a bistable gene
regulatory network comprising three genes - Bcl-6,
Blimp-1, and Pax5 - exhibits behavior consistent with
the terminal differentiation of B lymphocytes to anti-
body-secreting plasma cells. In a stochastic gene expres-
sion environment, the response to both antigen and
TCDD at the cell population level appears to be sub-
stantially graded even though activation of individual
cell is a binary, all-or-none phenomenon.
Additional file 1: Supplementary Materials. This file contains the
ordinary differential equations, parameter values, and initial steady-state
conditions for the B cell model presented in the main text, as well as
additional figures from model simulations.
Additional file 2: B cell model in SBML format. This file is the SMBL
version of the B cell model presented in the main text.
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